ReviewCancer science2018
Cancer immunotherapy-targeted glypican-3 or neoantigens.
Yasuhiro Shimizu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
35 papers cite it
this papertrialcites it
ReviewCancer science2018
Yasuhiro Shimizu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.